OMICS Publishing Group journal,Chemotherapy deals with the study & treatment of diseases using chemical agents/drugs, that are selectively toxic to the causative agent of the disease.
2. OPEN ACCESS: BENEFITS
Benefits to researchers, institutions, nations
& Society as whole.
For researchers, increased visibility raising
impact factor.
Benefit for researchers who can’t pay for
paper subscription.
As in today’s era of internet its free to access
research articles on related latest researches
to researchers & Scholars.
4. Chemotherapy deals with the study &
treatment of diseases using chemical
agents/drugs, that are selectively toxic to the
causative agent of the disease.
5. Make the research work freely accessible
globally through internet to share the
innovations of the researchers to scientific
community.
Chemotherapy aims to provide current
events, advantages and limitations in the
field of chemotherapy.
6. Chemotherapy: Open Access consists of
43 well qualified EB members throughout the
world mostly from USA, Japan, UK and some
other countries
7. EB MEMBER CATEGORISATION
Percentage
Others Cancer
15% Chemotherapy
Target for 17%
Chemotherapy Chemotherape
15% utic Agents
17%
Immunochemot
herapy Chemotherapy
14% Drugs
Chemotherapy:
12%
Treatment &
Side effects
10%
8. JOURNAL STATUS
Startedin 2011
Released first issue in March 2012
Recently Released Vol. 2, Issue 3
Releasing Vol 3, Issue 1 in Feb 2013
9. JOURNAL STATUS
30
29.5
No of Articles
29
28.5
28
27.5
27
Recieved Accepted Published
No. Of Articles 30 29 28
10. FUNDING ARTICLES
1 article funded by Japan Society for the
Promotion of Science and Smoking
Research Foundation.
Above 90% from high income country
11. Journal of Cancer Science & Therapy
Journal of Carcinogenesis & Mutagenesis
JCST started in 2009, Currently Vol 5, Issue 2
JCM started in 2010, Currently Vol. 3,Issue 2
12. RELATED JOURNALS FROM OTHER SOURCE
Journal of Chemotherapy (Maney Publishing)
Journal of Infection and Chemotherapy
(Springer)
Journal of chemotherapy (ResearchGate)
Journal of Antimicrobial Chemotherapy
(Oxford Journals)
International Journal Of Experimental &
Clinical Chemotherapy (Karger)
13. Two Special Issues has been approved for
Chemotherapy
Translational Pathology
Immunochemotherapy
14. RELATED CONFERENCES
Optimizing Outcomes in Colorectal Cancer Boston, United States of
America, 7th Feb 2013.
CHI's Targeting Cancer Stem Cells San Francisco, United States of
America, 11th Feb 2013.
16thScripps Cancer Center's 33rd Annual Clinical Hematology and
Oncology Conference San Diego, United States of America, 16th Feb
2013.
2nd Novel Cancer Therapeutics Summit Las Vegas, United States of
America, 25th Feb 2013.
24th Annual Cancer Progress Conference New York, United States
of America, 5th March 2013
15. 7th Conference on Experimental and Translational Oncology -
CETO Portoroz, Slovenia, 20th April 2013.
British Gynaecological Cancer Society Annual Scientific
Meeting Belfast , Ireland, 20th June 2013.
MASCC/ISOO 2013 International Cancer Care
Symposium Berlin, Germany, 27th June 2013.
27th17th ECCO - 38th ESMO - 32nd ESTRO European Cancer
Congress Amsterdam, Netherlands, 27th Sep 2013.
16. TO ADVERTISE THE JOURNAL AT CONFERENCES
Firstly advertise on the conference
website by placing banner ads with a
link to our website.
At the conference venue placing our
banners
Make use of pamphlets, Journal Digital
file to explain about our journals scope.
Inviting researchers attending related
conference by invitation letter and
17. INDEXING
It shows our table of content and abstracts
included in various online collections.
It increases visibility of our journal & perceived
quality of our journal.
It increases the ability to be searched for
information among various other publications.
18. INDEXING OF THE JOURNAL
Chemotherapy is indexed in
Google Scholar
OARE
Open J-Gate
DOAJ
COPERNICUS
SCRIUS
19. PLAN FOR INDEXING IN SCOPUS,MEDLINE,ISI
Issue release at regular interval.
Send invitations to quality person having
relevant field of interest as per the journal.
Coin special issue topics on recent ongoing
researches.
Updates EB profile every month based on
their designation, research interest etc.
Provide variable fee for different countries.
20. Gentle and polite communication in a
professional way with the researchers.
Form your own words at different situations
or for replies instead of same type of
communication to gain interest from
contributors.
Regular communication with EB members
and researchers for their suggestions and
contributors.
21. Updating status of EB member in website
regarding their designation, research
interest and ongoing projects, thus by
communicating regularly to gain interest
from them.
Accepting quality paper regardless of
country.
Providing variable fee for different
countries.
22. CONTACT US
Articles can be submitted to
editor.cmt@omicsonline.org
or
http://omicsgroup.org/editorialtracking/chemother
apy/SubmitManuscript.php
Website:
http://www.omicsgroup.org/journals/cmthome.php